Articles by Jim Miller - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jim Miller

Limits to Growth?

A major CRO ventures further into proprietary drug development.
Jun 8, 2009

A major CRO ventures further into proprietary drug development.

Penny-Wise, Pound-Foolish

Pharma companies that sell redundant facilities could endanger their supply chains.
Jun 2, 2009

Pharma companies that sell redundant facilities could endanger their supply chains.

Contract Organizations are the Sell of the Season

Despite the market downturn, private equity investors are lining up for pharmaceutical services.
May 6, 2009

Despite the market downturn, private equity investors are lining up for pharmaceutical services.

Limits to Growth?

A major CRO ventures further into proprietary drug development.
May 2, 2009

A major CRO ventures further into proprietary drug development.

The New Normal: The Changing Face of Pharma

When the business environment returns to "normal," our industry may appear quite different.
Apr 8, 2009

When the business environment returns to "normal," our industry may appear quite different.

Contract Organizations are the Sell of the Season

Despite the market downturn, private equity investors are lining up for pharmaceutical services.
Apr 2, 2009

Despite the market downturn, private equity investors are lining up for pharmaceutical services.

Strategic Service Partnerships Gain Momentum

Dire circumstances are driving major drug companies to seek out CRO partners. This article contains bonus online-exclusive material.
Mar 6, 2009

Dire circumstances are driving major drug companies to seek out CRO partners. This article contains bonus online-exclusive material.

The New Normal: The Changing Face of Pharma

When the business environment returns to "normal," our industry may appear quite different.
Mar 2, 2009

When the business environment returns to "normal," our industry may appear quite different.

Survival of the Fittest Companies

The financial crisis could lead to consolidation in the contract services industry.
Feb 4, 2009

The financial crisis could lead to consolidation in the contract services industry.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here